QRGenetics

QRGenetics is transforming the treatment of genetic diseases through GenAI-driven precision medicine. Our platform identifies and validates novel therapeutic targets by uncovering disease mechanisms in rare genetic conditions, rapidly matching them with clinically-proven, FDA-approved drugs and monitoring their validation in human trials. Leveraging these groundbreaking insights, QRGenetics then applies advanced AI analytics across extensive datasets to pinpoint similar targets in more common diseases. By partnering closely with pharmaceutical companies, we accelerate drug discovery, significantly reduce clinical risks, and bring effective treatments to broader patient populations faster. Join us on our journey to redefine precision medicine. Learn more: qrgenetics.com